InsidersTradesSigma
Track the 레이언스 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 레이언스 has recorded 6 public disclosures. Market capitalisation: €89.7bn. The latest transaction was disclosed on 9 March 2026 (Other). Among the most active insiders: 레이언스. The full history is free.
6
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Fundamental score
Ranked 19,738 of 29,063 companies
39.9
score / 100
Value47
Quality33
FCF yld7.7%
Earn yld-5.9%
EV/EBITDA·
ROE0.1%
Gross mgn36%
Net mgn-4.6%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 March 2026
Acerca de 레이언스
레이언스 es una empresa que opera en el sector farmacéutico y de la salud, cotiza en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para mejorar la salud del paciente.